Location History:
- Balerna, CH (2016 - 2017)
- Pordenone, IT (2012 - 2018)
- Mendrisio, CH (2018 - 2024)
Company Filing History:
24 out of 52 
1 out of 8 
1 out of 40 Years Active: 2012-2025
Title: Salvatore Bellinvia: Innovator in Inflammatory Disease Treatments
Introduction: Salvatore Bellinvia, based in Mendrisio, CH, is a notable inventor with an impressive portfolio of 25 patents. His innovative work primarily focuses on the development of therapeutic agents targeting inflammatory diseases, showcasing his commitment to advancing medical treatments.
Latest Patents: Among his latest contributions to the field are two significant patents. The first, titled "IL-34 antisense agents and methods of using same," discloses polynucleotides complementary to IL-34. This includes IL-34 antisense oligonucleotides and various methods aimed at treating inflammatory diseases such as inflammatory bowel disease and fibrosis, which are associated with the increased activity or expression of IL-34. The patent also encompasses pharmaceutical compositions containing these polynucleotides, offering new avenues for treatment options in the medical field.
The second patent, "Aryl receptor modulators and methods of making and using the same," is directed towards compounds that can bind to the aryl hydrocarbon receptor and modulate its activity. This invention provides methods for treating inflammatory conditions, including Crohn's disease, and pharmaceutical compositions that incorporate these innovative compounds. Additionally, it outlines methods for increasing IL-22 levels and decreasing IFN-γ levels in a patient, making this patent pivotal in the treatment of various inflammatory disorders.
Career Highlights: Salvatore has made substantial strides in his career, working with respected organizations such as Nogra Pharma Limited and Giuliani International Limited. His roles in these companies allowed him to focus on the practical applications of his research, leading to breakthroughs in inflammatory disease treatments.
Collaborations: Throughout his career, Salvatore has collaborated with talented individuals, including Francesca Viti and Sergio Baroni. These partnerships have enriched his work, contributing to the innovation and effectiveness of the inventions he has developed.
Conclusion: Salvatore Bellinvia exemplifies the spirit of innovation in the medical field. With his extensive patent portfolio and dedication to addressing inflammatory diseases, he remains a significant figure in pharmaceutical advancements. His work not only reflects his expertise but also points towards a future where improved treatments can enhance the quality of life for many individuals plagued by these conditions.